outcomes research

Research in Review

Aggressive Care Associated With Poorer Outcomes for Patients With NSCLC at End of Life

06/14/2017

JCP Editors

Aggressive care in the last month of life for patients with non–small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care. Patients with advanced NSCLC who are nearing...

...

06/14/2017

Journal of Clinical Pathways

Research in Review

Biologic Therapy Not Cost-Effective in Patients With RA

06/13/2017

JCP Editors

A cost-effectiveness analysis showed that patients with rheumatoid arthritis (RA) who switch from a disease-modifying antirheumatic drug (DMARD) to a biologic drug are likely to increase costs of care while receiving...

A...

06/13/2017

Journal of Clinical Pathways

Research in Review

High Response Rates With New Treatment for Aggressive B-Cell Lymphoma

06/13/2017

JCP Editors

In a recent trial, researchers determined complete response rates in patients with aggressive B-cell lymphomas after treatment with new a CAR T-cell product. ----- Related Content B-Cell ALL Disease Burden May...

In a...

06/13/2017

Journal of Clinical Pathways

Research in Review

Immunotherapy Improves Standard of Care for Multiple Myeloma

06/08/2017

JCP Editors

Adding a targeting agent to standard of care carfilzomib, lenalidomide, and dexamethasone (KRd) for multiple myeloma is a safe and efficacious alternative to autologous stem cell transplantation (ASCT) with KRd,...

Adding...

06/08/2017

Journal of Clinical Pathways

Research in Review

Early PET Scan Improves Outcomes for Patients With Hodgkin Lymphoma

06/08/2017

JCP Editors

Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...

...

06/08/2017

Journal of Clinical Pathways

Research in Review

Prolonged PFS, QoL in Ovarian Cancer After Maintenance Therapy

06/08/2017

JCP Editors

Women with BRCA-mutated relapsed serous ovarian cancer who received maintenance therapy after platinum-based chemotherapy prolonged their progression-free survival (PFS) by almost 7 months, according to results of a...

Women...

06/08/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Outcomes for Patients With MCL

06/08/2017

JCP Editors

Patients with mantle cell lymphoma (MCL) have increased odds of achieving complete remission after being treated with a combination regimen, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...

...

06/08/2017

Journal of Clinical Pathways

Research in Review

CAR T-Cells May Have Therapeutic Value in Solid Cancers

06/07/2017

JCP Editors

Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...

...

06/07/2017

Journal of Clinical Pathways

Research in Review

Metastatic Hormone-Na√Øve Prostate Cancer Effectively Treated With Combination Therapy

06/07/2017

JCP Editors

Groundbreaking results of a trial have shown that the combination of a new drug with androgen deprivation therapy (ADT) significantly improves overall survival (OS) and radiographic progression-free survival (PFS) in...

...

06/07/2017

Journal of Clinical Pathways

Gemcitabine-Based Chemoradiation Effective Bladder Cancer Treatment for Underdeveloped Nations

06/04/2017

JCP Editors

Neoadjuvant gemcitabine-based chemotherapy, followed by gemcitabine-based concomitant chemoradiation, may aid in bladder preservation for patients receiving treatment for muscle-invasive bladder cancer in...

...

06/04/2017

Journal of Clinical Pathways